This company has been marked as potentially delisted and may not be actively trading. NYSE:GEN Genesis Healthcare (GEN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrendsBuy This Stock About Genesis Healthcare Stock (NYSE:GEN) 30 days 90 days 365 days Advanced Chart Get Genesis Healthcare alerts:Sign Up Key Stats Today's Range$31.24▼$31.8850-Day Range$0.18▼$0.6052-Week Range$0.40▼$1.37Volume3.61 million shsAverage Volume4.10 million shsMarket Capitalization$20.18 billionP/E Ratio35.09Dividend Yield1.58%Price Target$33.25Consensus RatingModerate Buy Company Overview Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania. Read More Genesis Healthcare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks15th Percentile Overall ScoreGEN MarketRank™: Genesis Healthcare scored higher than 15% of companies evaluated by MarketBeat, and ranked 267th out of 308 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.3 / 5Analyst RatingModerate Buy Consensus RatingGenesis Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageGenesis Healthcare has received no research coverage in the past 90 days.Read more about Genesis Healthcare's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth5.52% Earnings GrowthEarnings for Genesis Healthcare are expected to grow by 5.52% in the coming year, from $1.63 to $1.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Genesis Healthcare is 35.09, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.43.Price to Earnings Ratio vs. SectorThe P/E ratio of Genesis Healthcare is 35.09, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 28.44. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for GEN. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldGenesis Healthcare pays a meaningful dividend of 3.05%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGenesis Healthcare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Genesis Healthcare is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Genesis Healthcare will have a dividend payout ratio of 29.07% next year. This indicates that Genesis Healthcare will be able to sustain or increase its dividend.Read more about Genesis Healthcare's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for GEN. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Genesis Healthcare this week, compared to 2 articles on an average week.Search Interest6 people have searched for GEN on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Genesis Healthcare insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.30% of the stock of Genesis Healthcare is held by insiders.Percentage Held by Institutions82.08% of the stock of Genesis Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Genesis Healthcare's insider trading history. Receive GEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address GEN Stock News HeadlinesRetirement home company with facilities in East Tennessee files for bankruptcyAugust 20 at 4:34 PM | msn.comGenesis Creditors Accuse Nursing Home Owner of ‘Rinse and Repeat’ BankruptciesAugust 14, 2025 | wsj.comThe Top 10 AI Stocks You Need to KnowDiscover the 10 Best AI Stocks to Buy Now! The AI revolution is reshaping the investment landscape, and knowing where to place your bets is crucial. Our free report reveals the 10 top AI stocks that should be on your radar right now. Don't miss your chance to get in on these high-potential tech plays.August 23 at 2:00 AM | TradingTips (Ad)Bankruptcy will not impact New Hampshire nursing facilities, says Genesis HealthCareAugust 5, 2025 | finance.yahoo.comOmega Healthcare raises 2025 AFFO guidance to $3.04–$3.07 per share while signaling robust acquisition pipelineAugust 2, 2025 | msn.comFirm Retention Summary: Genesis HealthcareAugust 2, 2025 | wsj.comPhil Collins issues health update amid claims he is receiving end-of-life-care in a hospiceJuly 29, 2025 | msn.comLifeServe, Genesis, plan Silvis blood driveJuly 26, 2025 | msn.comSee More Headlines GEN Stock Analysis - Frequently Asked Questions How were Genesis Healthcare's earnings last quarter? Genesis Healthcare, Inc. (NYSE:GEN) released its quarterly earnings data on Thursday, August, 1st. The company reported $0.53 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.53. The business's quarterly revenue was up 2.3% compared to the same quarter last year. Is Genesis Healthcare doing a stock buyback? Genesis Healthcare's Board of Directors initiated a stock buyback plan on Thursday, May 9th 2024, which authorizes the company to repurchase $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 23.1% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's leadership believes its stock is undervalued. What other stocks do shareholders of Genesis Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Healthcare investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE) and CrowdStrike (CRWD). Company Calendar Last Earnings8/01/2024Today8/23/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBusiness Services Industry Prepackaged software Sub-IndustryN/A Current SymbolNYSE:GEN Previous SymbolNYSE:SKH CIK849399 Webwww.genesishcc.com Phone610-444-6350Fax302-636-5454Employees2,700Year FoundedN/APrice Target and Rating Average Price Target for Genesis Healthcare$33.25 High Price Target$37.00 Low Price Target$30.00 Potential Upside/Downside+5.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$0.90 Trailing P/E Ratio35.09 Forward P/E Ratio19.37 P/E GrowthN/ANet Income$836 million Net Margins17.83% Pretax Margin23.69% Return on Equity155.48% Return on Assets9.12% Debt Debt-to-Equity Ratio7.50 Current Ratio0.48 Quick Ratio0.48 Sales & Book Value Annual Sales$2.80 billion Price / Sales7.22 Cash Flow$3.75 per share Price / Cash Flow8.42 Book Value($0.16) per share Price / Book-197.38Miscellaneous Outstanding Shares639,130,000Free Float618,038,000Market Cap$20.18 billion OptionableOptionable Beta0.84 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NYSE:GEN) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genesis Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.